To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer

NCT01222780 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Sarcoma
Neuroblastoma
Wilms Tumor
Leukemia
Lymphoma
Brain Tumors

Interventions

DRUG: Marqibo

Sponsor

Acrotech Biopharma Inc.

Collaborators

[object Object]